secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zura Bio Ltd (ZURA)
CIK:        0001855644
Form:       8-K
Filed at:   2025-07-01T23:59:59+00:00
Accession:  0001104659-25-064427
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zura Bio appoints Eric Hyllengren as CFO; Verender Badial steps down effective July 7, 2025
--------------------------------------------------------------------------------

- Eric Hyllengren appointed CFO effective July 7, 2025; previously COO/CFO at Atara Biotherapeutics and 15 years at Amgen.
- Verender Badial resigns as CFO, stays as non-executive employee through July 31, 2025 to assist transition.
- Badial receives £178,294.92 cash severance, accelerated vesting for 186,561 options; 303,100 options forfeited.
- Hyllengren gets $475,000 base salary, 40% target bonus, and option for 672,000 shares vesting over 4 years.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855644/000110465925064427/0001104659-25-064427-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855644/000110465925064427/tm2519325d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-064427

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer